You are here

Share:

Improved Pepper Spray for Repellency and Incapacitation

Summary
The National Cancer Institute seeks partners to license a composition for use in an aerosol or spray, that when administered, causes a painful stimulation and incapacitates a person for only a brief period.
NIH Reference Number
E-048-2010
Product Type
Keywords
  • Pepper spray, incapacitation, safety aerosol
  • non-lethal weapon
Collaboration Opportunity
This invention is available for licensing.
Contact
Description of Technology

Non-lethal means of temporarily incapacitating a person are greatly needed for law enforcement and for personal protection.  A common approach is to use pepper spray.  Although current pepper sprays are effective, they cause pain for excessively long periods, and could be life threatening for people who suffer from asthma and have hypersensitive airways.  This technology describes a composition for use in an aerosol or spray, that when administered, causes a painful stimulation and incapacitates a person for only a brief period. This technology may improve safety over currently available pepper sprays.

Potential Commercial Applications
  • Law enforcement (policing, riot control, crowd control)
  • Incapacitating agent for use in hostage situations
  • Personal self-defense, non-lethal weapons
Competitive Advantages
  • Incapacitating pepper spray with reduced toxicity and enhanced safety.
  • May reduce potential agency liability in case of an adverse response of an individual who was sprayed (due to reduced toxicity may not be as life threatening to those suffering from asthma or have hypersensitive airways as standard pepper sprays).
  • Mixture can be incorporated into a spray, aerosol, or other dispersions.
Development Stage
Patent Status
  • U.S. Provisional: U.S. Provisional Patent Application Number 61/340,063, Filed 12 Mar 2010
  • Foreign Filed: - Patent Application PCT/US2011/028132, Filed 11 Mar 2011
  • Foreign Filed: Canadian - Patent Application 2,792, 878, Filed 11 Mar 2011
  • U.S. Patent Filed: U.S. Patent Application Number 13/634,447, Filed 12 Sep 2012
  • U.S. Patent Filed: U.S. Patent Application Number 15/010,830, Filed 29 Jan 2016
Therapeutic Area
Updated
Tuesday, December 19, 2017